OriGene Logo
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
Home CRISPR-CAS9 KN200042

BCL2L13 - human gene knockout kit via CRISPR


Specifications  Citations  Validation Data  FAQ
SKU Description Price Availability Manual  
KN200042 BCL2L13 - human gene knockout kit via CRISPR $1200 4 Weeks Manual PDF Add to Shopping Cart
Also for BCL2L13 (Locus ID 23786)
cDNA Clone shRNA/siRNA CRISPR KO Kit Protein Request Antibody
SKU Description Donor Vector Price Availability  
KN200042RB BCL2L13 - human gene knockout kit via CRISPR RFP-BSD 1290 4 Weeks
KN200042LP BCL2L13 - human gene knockout kit via CRISPR Luciferase-Puro 1290 4 Weeks
KN200042BN BCL2L13 - human gene knockout kit via CRISPR mBFP-Neo 1290 4 Weeks
Add to Shopping Cart

Comparing to KN200042, the above kits contain:

  • Identical gRNA vectors
  • Identical LHA & RHA
  • Different donor cassette
Kit Components
KN200042G1, BCL2L13 gRNA vector 1 in pCas-Guide vector
KN200042G2, BCL2L13 gRNA vector 2 in pCas-Guide vector
KN200042D, donor vector containing Left and right homologous arms and GFP-Puro functional cassette.
GE100003, scramble sequence in pCas-Guide vector

The kit is designed based on the best knowledge of CRISPR technology. The system has been functionally validated for knocking-in the cassette downstream the native promoter. The efficiency of the knock-out varies due to the nature of the biology and the complexity of the experimental process.

Reference Data
RefSeq: AF246665NM_001270726NM_001270727NM_001270728NM_001270729NM_001270730NM_001270731NM_001270732NM_001270733NM_001270734NM_001270735NM_015367NR_073068NR_073069XM_011546119XM_011546120XM_011546121XM_011546123XM_017028725XM_017028726XM_017028727XM_017028728XM_017028729XM_017028730XM_017028731XM_017028732XM_017028733XM_017028734XR_001755196
Synonyms: BCL-RAMBO; Bcl2-L-13; MIL1
Summary: May promote the activation of caspase-3 and apoptosis. [UniProtKB/Swiss-Prot Function]

Learn more about CRISPR?

Diagram-Gene Editing RecombII


Inc 5000 Healthcare Company